Europos Sąjunga - norvegų - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Norvegija - norvegų - Statens legemiddelverk

jazz pharmaceuticals ireland limited - dronabinol / cannabidiol - munnspray, oppløsning - 27 mg/ ml / 25 mg/ ml

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cystisk fibrose - andre åndedrettsprodukter - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Norvegija - norvegų - myHealthbox

dentaworks - mundhygiejne; tandplejetilbehør

Norvegija - norvegų - myHealthbox

dentaworks - mundhygiejne; tandplejetilbehør

Norvegija - norvegų - myHealthbox

dentaworks - mundhygiejne; tandplejetilbehør

Norvegija - norvegų - Statens legemiddelverk

medical valley invest ab - tapentadoltartrat - depottablett - 250 mg

Norvegija - norvegų - Statens legemiddelverk

medical valley invest ab - tapentadoltartrat - depottablett - 50 mg

Norvegija - norvegų - Statens legemiddelverk

medical valley invest ab - tapentadoltartrat - depottablett - 100 mg